posted on 2015-04-07, 00:00authored byDebrina Jana, Carlos Matti, Jie He, Laura Sagle
We report the first assessment of
the plasmonic biosensing capabilities
of capping agent-free gold nanostars. Capping agent removal was carried
out using aqueous solutions of sodium borohydride, which yielded a
refractive index sensitivity of 474 nm/RIU for the polyvinylpyrrolidone
(PVP)-free nanostars compared with 98 nm/RIU for PVP-coated gold nanostars.
Following PVP removal, biotinylated thiol and streptavidin protein
were added to the nanostars, which resulted in red shifts as large
as 51 nm and a limit of detection as low as 0.1 pM. Refractive index-based
sensing of prostate specific antigen (PSA) both in buffer and serum
was then carried out and was shown to yield shifts as large as 127
nm and have a limit of detection of 100 pM in serum. Last, a sandwich
assay involving PSA was developed to aggregate the nanostars together
for greater sensitivity. The sandwich assay did, indeed, give shifts
close to 200 nm and was capable of detecting 10–17 M PSA in serum. The greatly increased sensitivity and amenability
to functionalization of PVP-free gold nanostars should prove useful
in applications ranging from catalysis to drug delivery.